June 24, 2022 - A life-changing treatment to reverse injury-related sight loss is now available to patients at specialist centres across England, thanks to a partnership between Newcastle Hospitals and Italian medicines manufacturer, Holostem. The specialist advanced therapy, known as…
Translation of the article by Alberto Greco - published in Il Resto del Carlino Modena, 25 July 2021 While people in Germany, Belgium and Holland were fighting against the devastation caused by the terrible floods of the past few days…
Modena, Italy / Brno, Czech Republic, May 12, 2021 - Holoclar®, the first stem cell-based medicinal product approved and formally registered in the Western world in 2015, is now available also in Czech Republic. Holoclar®, manufactured and distributed by Holostem…
Cary, N.C., and Modena, Italy, June 12, 2018 – Chiesi USA (key-A-zee), a specialty pharmaceutical company based in Cary, N.C., and the Italian biotech Holostem Terapie Avanzate S.r.l., announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug…
Parma/Modena (Italy), February 20, 2015 – The European Commission has granted a conditional marketing authorization, under Regulation (EC) No 726/2004, to Holoclar®, an advanced therapy based on autologous stem cells and capable to restore the eyesight of patients with severe cornea…
